Innov Clin Neurosci. 2025;22(7–9):24–27. by Muqadas Fatima, MS, and Uzma Ilyas, PhD Ms. Fatima is serving as Lecturer at National University of Modern Languages (NUML) in Lahore, Pakistan. Dr. Ilyas
Innov Clin Neurosci. 2025;22(7–9):32–39. by Ray M. Merrill, PhD, MPH Dr. Merrill is with the Department of Public Health in the College of Life Sciences at Brigham Young University in
Innov Clin Neurosci. 2025;22(7–9):40–41. by Adil Tumbi, MD; Amit Mistry, MD; BreAnna-Anh Le, BS; and Steven Lippmann, MD Drs. Tumbi and Mistry are with the Oklahoma City Veteran Affairs Health
Innov Clin Neurosci. 2025;22(7–9):42–43. by Akemini “Kem” Isang, RN, JD Ms. Isang is a Risk Manager at Professional Risk Management Services (PRMS). FUNDING: No funding was provided for the preparation
Innov Clin Neurosci. 2025;22(4–6):11–13. Dear Editor: We read with interest the article by Free et al1 about a 32-year-old female patient with a history of migraine, gastroesophageal reflux disease (GERD)
Innov Clin Neurosci. 2025;22(4–6):11–13. Dear Editor: We greatly appreciate the letter to the editor regarding the article “Compulsive Biting and Chewing with Mixed Amphetamine Salts: A Case Report” by Free
Innov Clin Neurosci. 2025;22(4–6):11–13. Dear Editor: Approximately 15 years have passed since functional near-infrared spectroscopy (fNIRS) was approved for use as an auxiliary diagnostic tool for the differential diagnosis of
by Samara White, PharmD; Tammie Lee Demler, PharmD, MBA, BCGP, BCPP; and Eileen Trigoboff, RN, PMHCNS-BC, DNS, DABFN Drs. White and Demler are with The New York State Office of
by Ahmed Aboraya, MD, DrPH; Daniel Elswick, MD; James Berry, DO; Dilip Chandran, MD; Cheryl Hill, MD; Wanhong Zheng, MD; Jeremy D. Hustead, MD; Dorothy Van Oppen, MD; Vishal Patel,
by Rabeel Ahmad, DO; Samantha Shor, DO; Genesy Aickareth, BS; Roselyn Chiyezhan, BS; Meghna Mathews, BS; Isabel Chacko, BS; Brett Pontelandolfo, BS; and Joanne Mathews, MD Dr. Ahmad is with
by Larrilyn Grant, MD, MS; Kari Harper, MD; and Julie P. Gentile, MD, MBA All authors are with the Department of Psychiatry at Wright State University in Dayton, Ohio. FUNDING:
by Devendra Kumar Singh Varshney, PhD; Manju Agrawal, PhD; Rakesh Kumar Tripathi, PhD, MPhil; and Satish Rasaily, MD Dr. Varshney is with DCV Institute of Indology in Lucknow, India. Dr.
by Charles D. Cash, JD, LLM Mr. Cash is Associate Director of Risk Management at Professional Risk Management Services (PRMS). FUNDING: No funding was provided for the preparation of this
Innov Clin Neurosci. 2025;22(1–3):11–13. Dear Editor: I read with interest Lawrence’s article about a 33-year-old male patient with migraine with aura who self-experimented with psilocybin for his migraine attacks, which
Innov Clin Neurosci. 2025;22(1–3):11–13. Dear Editor: Thank you for your interest in this case report1 and for your insightful comments. I appreciate the thoroughness of your feedback and concur with
Innov Clin Neurosci. 2025;22(1–3):11–13. Dear Editor: Emerging data on sex differences in the efficacy and tolerability of antipsychotics in patients with schizophrenia are not taken into account in current guidelines,
by Eirini Beneki, MSc, MD, PhD(c); Kyriakos Dimitriadis, MD, PhD; Elias Zintzaras, MD, PhD; Panagiotis Kostakis, MD, PhD(c); Constantina Aggeli, MD, PhD; and Konstantinos Tsioufis, MD, PhD Drs. Beneki, Dimitriadis,
by Terry Correll, DO; Julie Gentile, MD, MBA; and Andrew B. Correll, MD Dr. T. Correll is Clinical Professor, Department of Psychiatry, Wright State University Boonshoft School of Medicine in
by Ragaviveka Gopalan, BSc, MS; Himanshi Pande, BA; Saralya Narayanan, BSc; and Adith Chinnaswami, MS, MBBS Ms. Gopalan and Dr. Chinnaswami are with MediSim VR in Chennai, India. Ms. Pande
Helping Exceptionally Sensitive Patients See Their Sensitivity as a Gift
Innov Clin Neurosci. 2025;22(7–9):28–31. by Edmund G. Howe, MD, JD Dr. Howe is with Uniformed Services University of the Health Sciences in Bethesda, Maryland. FUNDING: No funding was provided for
Read More